Education
About Us
Working with TipRanks
Follow Us
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 605.50K | C$ 1.04M | C$ 532.00K | C$ 78.07K | C$ 0.00 |
| Gross Profit | C$ -845.17K | C$ 887.44K | C$ 454.10K | C$ 75.78K | C$ -303.00 |
| Operating Income | C$ -2.15M | C$ -643.57K | C$ -762.95K | C$ -985.58K | C$ -2.51M |
| EBITDA | C$ -2.07M | C$ -573.36K | C$ -710.18K | C$ -973.45K | C$ -2.51M |
| Net Income | C$ -2.18M | C$ -823.60K | C$ -779.81K | C$ -985.58K | C$ -2.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 960.66K | C$ 419.38K | C$ 195.04K | C$ 852.14K | C$ 2.47M |
| Total Assets | C$ 3.42M | C$ 2.90M | C$ 2.41M | C$ 2.33M | C$ 2.79M |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 253.54K | C$ 0.00 | C$ 0.00 |
| Net Debt | C$ -40.19K | C$ -419.38K | C$ 58.49K | C$ -852.14K | C$ -2.47M |
| Total Liabilities | C$ 961.73K | C$ 916.88K | C$ 1.03M | C$ 423.78K | C$ 138.48K |
| Stockholders' Equity | C$ 2.46M | C$ 1.98M | C$ 1.38M | C$ 1.91M | C$ 2.66M |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.05M | C$ -547.78K | C$ -846.39K | C$ -1.62M | C$ -435.76K |
| Operating Cash Flow | C$ -1.04M | C$ -321.36K | C$ -339.66K | C$ -625.37K | C$ -173.57K |
| Investing Cash Flow | C$ -935.27K | C$ -226.42K | C$ -506.74K | C$ -994.87K | C$ 629.22K |
| Financing Cash Flow | C$ 1.60M | C$ 772.12K | C$ 189.29K | C$ 0.00 | C$ 2.02M |
PharmAla Biotech Holdings, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.